Busse, William W <br/><br/>
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.  [electronic resource] 

 -  The New England journal of medicine  Mar 2011 
 - 1005-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1009705  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Animals<br/>Anti-Asthmatic Agents--adverse effects<br/>Antibodies, Anti-Idiotypic--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Asthma--drug therapy<br/>Child<br/>Cockroaches--immunology<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Dust--analysis<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Immunoglobulin E--blood<br/>Male<br/>Omalizumab<br/>Poverty Areas<br/>Practice Guidelines as Topic<br/>Seasons<br/>Urban Population